Straumann and the French dental implant manufacturer Anthogyr have announced a partnership agreement that enables the Swiss company to invest in Anthogyr and to address a broader section of the fast-growing tooth replacement market in China.
Anthogyr’s dental implant system is registered and established in China where it is positioned as a high-quality, attractively-priced option. The agreement foresees the transfer of Anthogyr’s implantology business activities in China to Straumann by midyear, giving the latter access to the fast-growing value segment there. The combination of the two companies’ sales capabilities is expected to provide the critical mass to compete and grow successfully in this segment. Straumann already leads the premium segment in China and has recently established a new country organization and distributor network covering all provinces.
In addition, Straumann is to acquire a 30% stake in Anthogyr and offers potential leverage to the business in other markets through Instradent, the business platform that Straumann is building to address the global value segment with multiple brands. Financial details were not disclosed and the agreement is expected to become effective at the end of March, subject to the fulfilment of certain conditions.
Disclaimer: This release contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expressed or implied in this release. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any statements contained in it as a result of new information, future events or otherwise.
Source: Straumann/Anthogyr press release 25 February 2016
